RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

Conditions: COPD Exacerbation Acute; COPD With Acute Lower Respiratory Infection; Rhinovirus; Virus Diseases; Virus Infection, RNA; Enterovirus; Enterovirus Infections; Rhinovirus Infection; Infection Viral; Respiratory Complication; Respiratory Disease; Respiratory Tract Infections; Respiratory Tract Diseases; Respiratory Viral Infection; Upper Resp Tract Infection; Upper Respiratory Tract Infections; Upper Respiratory Disease; Upper Respiratory Disorder; Upper Respiratory Disease, Acute; Upper Respiratory Infection Viral; Infections, Respiratory; Infections; Copd; Viral Infection; Emphysema or COPD; Lower Respiratory Disease; Lower Respiratory Disorder; Lower Respiratory Tract and Lung Infections; Pulmonary Disease; Pulmonary Disease, Chronic Obstructive; Respiratory Disease Chronic; Lung Diseases; Lung Disease Chronic; Obstructive Pulmonary Disease; Chronic Lower Respiratory Diseases; Chronic Respiratory Disease Interventions: Drug: Vapendavir; Drug: Placebo Sponsors: Altesa Biosciences, Inc.; Virtus Respiratory Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials